Developing & Licensing the
Please remove this image from the source code.World’s Strongest, Most
Effective Broad-SpectrumVitastem Ultra is Antibiotics for
Infectious Skin Diseases and Wound Care.

Our Innovative


Developing & Licensing the World’s Strongest, Most Effective Broad-Spectrum Antibiotics for Infectious Skin Diseases and Wound Care.

Our Innovative

About Our Transdermal Technology

Strong Advanced Biological Coverage (ABC) topical antibiotics that are highly concentrated, penetrate faster, and much more effective than conventional antibiotics. Our advanced transdermal delivery system kills all harmful gram-positive & gram-negative bacteria that are available for testing and delivers results within 24 hours, compared to 5-7 days for others.

More Effective Than Conventional Antibiotics
More Shelf Life Than Conventional Antibiotics
More Usability Than Conventional Antibiotics
Solutions

Our Target Markets Globally

Client Testimonials
Vitastem Ultra First Aid & Antibiotic
New Antibiotic
Strongest First Aid & Antibiotic
Kills all type of bacteria

New Antibiotic Vitastem Ultra

A New FDA-Registered & Patent Pending Topical Antibiotic

Strongest First Aid & Antibiotic Vitastem Ultra

One of The World’s Strongest Topical First Aid & Antibiotics for OTC Use.

Kills all type of bacteria

Vitastem Ultra kills all harmful bacteria that have ever been available for testing (bacteria associated with acne, eczema, psoriasis, diabetic wounds, cuts & scrapes), including staph infection, and MRSA (flesh eating bacteria).

Vitastem Ultra First Aid & Antibiotic
New Antibiotic

New Antiniotic

A New FDA-Registered & Patent Pending Topical Antibiotic

Strongest First Aid & Antibiotic

Strongest First Aid & Antibiotic

One of The World’s Strongest Topical First Aid & Antibiotics for OTC Use.

Kills all type of bacteria

Kills all type of bacteria

Vitastem Ultra kills all harmful bacteria that have ever been available for testing (bacteria associated with acne, eczema, psoriasis, diabetic wounds, cuts & scrapes), including staph infection, and MRSA (flesh eating bacteria).

ViaDerma Has Been Featured In

Founded in 2014 by Dr. Christopher Otiko, ViaDerma Inc. (VDRM) is a publicly traded pharmaceutical company committed to bringing new products to market and licensing its innovative technology to current leaders in the pharmaceutical industry in a wide variety of therapeutic areas.

ViaDerma’s lead product Vitastem utilizes an innovative transdermal delivery method to apply any active ingredient to a topical drug.

ViaDerma Featured in Digital Journal
ViaDerma Featured in US Healthcare Journal
ViaDerma Featured in AP News
ViaDerma Featured in Healthcare Industry Today
ViaDerma Featured in Business Insider
ViaDerma Featured in Azcentral
ViaDerma Featured in Benzinga
ViaDerma Featured in Yahoo Finance
ViaDerma Featured in MarketWatch
ViaDerma Featured in UK Herald
Lets Stay Healthy
With Via Derma